BBVA
BSX icon

Banco Bilbao Vizcaya Argentaria’s Boston Scientific BSX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Sell
113,479
-11,295
-9% -$613K 0.03% 297
2026
Q1 		$7.81M Sell
124,774
-10,376
-8% -$830K 0.05% 223
2025
Q4 		$12.9M Buy
135,150
+30,365
+29% +$2.98M 0.09% 179
2025
Q3 		$10.2M Buy
104,785
+69,174
+194% +$7.16M 0.08% 193
2025
Q2 		$3.82M Sell
35,611
-42,170
-54% -$4.27M 0.03% 305
2025
Q1 		$7.85M Buy
77,781
+843
+1% +$84.9K 0.08% 207
2024
Q4 		$6.87M Sell
76,938
-17,093
-18% -$1.5M 0.07% 227
2024
Q3 		$7.88M Buy
94,031
+42,190
+81% +$3.33M 0.08% 214
2024
Q2 		$3.99M Sell
51,841
-2,043
-4% -$150K 0.04% 296
2024
Q1 		$3.69M Buy
53,884
+1,639
+3% +$105K 0.04% 326
2023
Q4 		$3.02M Buy
52,245
+2,434
+5% +$130K 0.04% 363
2023
Q3 		$2.63M Sell
49,811
-20,925
-30% -$1.1M 0.04% 370
2023
Q2 		$3.83M Sell
70,736
-44,044
-38% -$2.3M 0.05% 313
2023
Q1 		$5.74M Sell
114,780
-73,224
-39% -$3.45M 0.07% 253
2022
Q4 		$8.74M Sell
188,004
-37,585
-17% -$1.63M 0.13% 189
2022
Q3 		$8.7M Buy
225,589
+10,582
+5% +$425K 0.14% 156
2022
Q2 		$8.01M Buy
215,007
+40,165
+23% +$1.63M 0.12% 167
2022
Q1 		$7.77M Buy
174,842
+5,538
+3% +$240K 0.11% 182
2021
Q4 		$7.2M Buy
169,304
+30,196
+22% +$1.27M 0.1% 187
2021
Q3 		$6.05M Sell
139,108
-3,423
-2% -$151K 0.1% 186
2021
Q2 		$6.14M Sell
142,531
-38,736
-21% -$1.63M 0.11% 170
2021
Q1 		$6.99M Buy
181,267
+68,312
+60% +$2.59M 0.14% 131
2020
Q4 		$4.06M Sell
112,955
-12,177
-10% -$439K 0.09% 193
2020
Q3 		$4.78M Buy
125,132
+18,148
+17% +$699K 0.14% 133
2020
Q2 		$3.76M Sell
106,984
-7,026
-6% -$253K 0.12% 145
2020
Q1 		$3.72M Buy
114,010
+31,046
+37% +$1.21M 0.13% 152
2019
Q4 		$3.75M Buy
+82,964
New +$3.47M 0.12% 191

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BSX Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Boston Scientific (BSX) stake by 9.1% in Q2 2026, selling an estimated $613K and leaving 113,479 shares worth $4.84M. The position accounts for 0.03% of the portfolio, ranked #297.

Banco Bilbao Vizcaya Argentaria first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.9M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 113,479 shares of Boston Scientific worth $4.84M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 11,295 Boston Scientific shares in Q2 2026, an estimated $613K.
  • Boston Scientific made up 0.03% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #297 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Boston Scientific position peaked at $12.9M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.